Abstract Previous studies have shown that peripheral nerve injury can lead to abnormal dendritic spine remodeling in spinal dorsal horn neurons. Inhibition of abnormal dendritic spine remodeling can relieve neuropathic pain. Electroacupuncture (EA) has a beneficial effect on the treatment of neuropathic pain, but the specific mechanism remains unclear. Evidence has shown that slit-robo GTPase activating protein 3 (srGAP3) and Rho GTPase (Rac1) play very important roles in dendritic spine remodeling. Here, we used srGAP3 siRNA and Rac1 activator CN04 to confirm the relationship between SrGAP3 and Rac1 and their roles in improving neuropathic pain with EA. Spinal nerve ligation (SNL) was used as the experimental model, and thermal withdrawal latency (TWL), mechanical withdrawal threshold (MWT), Western blotting, immunohistochemistry and Golgi-Cox staining were used to examine changes in behavioral performance, protein expression and dendritic spines. More dendritic spines and higher expression levels of srGAP3 were found in the initial phase of neuropathic pain. During the maintenance phase, dendritic spines were more mature, which was consistent with lower expression levels of srGAP3 and higher expression levels of Rac1-GTP. EA during the maintenance phase reduced the density and maturity of dendritic spines of rats with SNL, increased the levels of srGAP3 and reduced the levels of Rac1-GTP, while srGAP3 siRNA and CN04 reversed the therapeutic effects of EA. These results suggest that dendritic spines have different manifestations in different stages of neuropathic pain and that EA may inhibit the abnormal dendritic spine remodeling by regulating the srGAP3/Rac1 signaling pathway to alleviate neuropathic pain.

ABSTRACT Purpose: To investigate the underlying mechanism of hepatic sinusoidal obstruction syndrome (HSOS) induced by Gynura segetum by measuring autophagy in mouse models. Methods: The model group was administered G. segetum (30 g/kg/d) by gavage, while the normal control group was administered an equal volume of saline daily for five weeks. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hepatic histopathological examinations, and Masson staining were performed to evaluate liver injury. Liver intercellular adhesion molecule-1 (ICAM-1) and P-selectin were evaluated by immunohistochemistry. Hepatocellular apoptosis was assessed using the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Protein expression levels of autophagy markers were measured using Western blot analysis. Results: Gynura segetum was found to significantly induce liver injury compared with control mice, as evidenced by the increase of serum transaminases, a decrease in triglyceride levels, and histopathological changes in mice. Gynura segetum remarkably induced hepatocellular apoptosis and upregulated the expressions of ICAM-1 and P-selectin and also downregulated the protein expression levels of LC3, Atg12 and cytoplasmic polyadenylation element binding protein. Conclusions: Our results suggested that G. segetum induced liver injury with HSOS, and it was partly due to its ability to impair the autophagy pathway.

Tubular-interstitial nephritis (TIN) is characterized by tubular cell damage and inflammatory lesions of kidneys. Baicalein (BAI) is a flavonoid compound found in the roots of Scutellaria baicalensis Georgi. The present study was undertaken to explore the anti-inflammatory and anti-oxidative effects of BAI on TIN patients and a lipopolysaccharide (LPS)-induced TIN cell model. The expression levels of interleukin-6 (IL-6), IL-10, and tumor necrosis factor α in serum samples of TIN patients and culture supernatants of renal proximal tubular epithelial cells (RPTECs) were evaluated using enzyme-linked immunosorbent assay. Creatinine clearance was calculated using the Cockcroft-Gault equation. Activities of malondialdehyde, superoxide dismutase, and glutathione peroxidase were also determined. Viability and apoptosis of RPTECs were measured using MTT assay and Guava Nexin assay, respectively. qRT-PCR was performed to determine the expressions of Bax, Bcl-2, nuclear factor kappa B (IκBα), and p65. Protein levels of Bax, Bcl-2, IκBα, p65, c-Jun N-terminal kinase, extracellular regulated protein kinases, and p38 were analyzed using western blotting. We found that BAI reduced inflammation and oxidative stress in vivo and in vitro. Moreover, BAI alleviated the LPS-induced RPTECs viability inhibition and apoptosis enhancement, as well as nuclear factor kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) activation. Phorbol ester, an activator of NF-κB, attenuated the effects of BAI on LPS-induced inflammatory cytokine expressions in RPTECs. In conclusion, BAI had anti-inflammatory and anti-oxidative effects on TIN patients and LPS-induced RPTECs by down-regulating NF-κB and MAPK pathways.

ABSTRACT A better understanding of the antimicrobial susceptibility, carriage of virulence determinants and molecular characteristics of Staphylococcus aureus isolates associated with skin and soft tissue infections (SSTIs) may provide further insights related to clinical outcomes with these infections. From January 2012 to September 2013, a total of 128 non-duplicateS. aureus isolates were recovered from patients with SSTIs. All 128 S. aureus SSTI isolates carried at least five virulence genes tested. Virulence genes detected among at least 70% of all tested isolates included hld (100%), hla (95.3%),icaA (96.9%), clf (99.2%),sdrC (79.7%), sdrD (70.3%), andsdrE (72.7%). The prevalence of MRSA isolates with 10 virulence genes tested (54.4%, 31/56) was significantly higher than that among MSSA isolates (35.2%, 25/71) (p < 0.05). The positive rates of seb, sen, sem, sdrE and pvl among MRSA isolates were significantly higher than among MSSA isolates (p< 0.05). ST7 and ST630 accounting for 10.9% were found to be the predominant STs. The most prevalent spa type was t091 (8.6%). MRSA-ST59-SCCmec IV was the most common clone (12.3%) among MRSA isolates whereas among MSSA isolates the dominant clone was MSSA-ST7 (15.5%). Six main clonal complexes (CCs) were found, including CC5 (52.3%), CC7 (11.7%), CC59 (8.6%), CC88 (6.3%), CC398 (4.7%), and CC121 (3.1%). A higher carriage of seb and sec was found among CC59 isolates. In comparison to CC5 and CC7 isolates, those with the highest carriage rates (>80.0%) of sdrC and sdrD, CC59 isolates had lower prevalence of these two virulence genes. All CC59 isolates were susceptible to gentamicin and trimethoprim/sulfamethoxazole, while CC5 and CC7 isolates had resistance rates to these two antimicrobials of 25.4% and 20.9%, and 40.0% and 40.0%, respectively. The resistance rates for tetracycline, clindamycin, and erythromycin among CC5 isolates were lower than among CC7 and CC59 isolates. In conclusion, the molecular typing of S. aureusSSTI isolates in the present study showed considerable heterogeneity. ST7 and ST630 became prevailing clones. Different S. aureus clones causing SSTIs were associated with specific antimicrobial resistance and virulence gene profiles.

Objective To analyse the epidemiology of measles in China and determine the progress made towards the national elimination of the disease. Methods We analysed measles surveillance data – on the age, sex, residence and vaccination status of each case and the corresponding outcome, dates of onset and report and laboratory results – collected between January 2005 and October 2013. Findings Between 2005 and October 2013, 596 391 measles cases and 368 measles-related deaths were reported in China. Annual incidence, in cases per 100 000 population, decreased from 9.95 in 2008 to 0.46 in 2012 but then rose to more than 1.96 in 2013. The number of provinces that reported an annual incidence of less than one case per million population increased from one in 2009 to 15 in 2012 but fell back to one in 2013. Median case age decreased from 83 months in 2005 to 14 months in 2012 and 11 months in January to October 2013. Between 2008 and 2012, the incidence of measles in all age groups, including those not targeted for vaccination, decreased by at least 93.6%. However, resurgence started in late 2012 and continued into 2013. Of the cases reported in January to October 2013, 40% were aged 8 months to 6 years. Conclusion Although there is evidence of progress towards the elimination of measles from China, resurgence in 2013 indicated that many children were still not being vaccinated on time. Routine immunization must be strengthened and the remaining immunity gaps need to be identified and filled.

Resumen Objetivo Analizar la epidemiología del sarampión en China y determinar el progreso hecho hacia la erradicación nacional de la enfermedad. Métodos Hemos analizado los datos de vigilancia del sarampión recogidos entre enero de 2005 y octubre de 2013 en base a la edad, el sexo, la residencia y el estado de vacunación de cada caso y el resultado correspondiente, las fechas de inicio de la enfermedad y de su comunicación, y los resultados de laboratorio. Resultados Entre 2005 y octubre de 2013, se registraron 596 391 casos de sarampión y 368 muertes relacionadas con el sarampión en China. La incidencia anual, en casos por 100 000 habitantes, descendió del 9,95 en 2008 al 0,46 en 2012, pero volvió a aumentar en el 2013 hasta más del 1,96. El número de provincias que informó acerca de una incidencia anual de menos de un caso por millón de habitantes aumentó de una en 2009 a 15 en 2012, pero volvió a caer a una en 2013. La edad media de los casos disminuyó de 83 a 14 meses en 2012, y a 11 meses de enero a octubre de 2013. Entre 2008 y 2012, la incidencia del sarampión en todos los grupos de edad, incluidos los que no estaban incluidos en la vacunación, se redujo en al menos un 93,6 %. Sin embargo, un resurgimiento comenzó a finales de 2012 y continuó en 2013. De los casos comunicados de enero a octubre de 2013, el 40 % tenía entre 8 meses y 6 años. Conclusión Aunque hay pruebas de los progresos hacia la erradicación del sarampión en China, el resurgimiento en el año 2013 mostró que todavía hay muchos niños que no reciben la vacuna a tiempo. Es necesario reforzar la vacunación sistemática e identificar y completar las lagunas restantes en la inmunización.

Résumé Objectif Analyser l'épidémiologie de la rougeole en Chine et déterminer les progrès réalisés sur la voie de l'élimination nationale de la maladie. Méthodes Nous avons analysé les données de surveillance de la rougeole – concernant l'âge, le sexe, le lieu de résidence et le statut vaccinal de chaque cas et les résultats correspondants, les dates de l'apparition et de signalement de la maladie, et les résultats de laboratoire –collectées entre janvier 2005 et octobre 2013 Résultats Entre 2005 et octobre 2013, 596 391 cas de rougeole et 368 décès liés à la rougeole ont été signalés en Chine. L'incidence annuelle exprimée en cas pour 100 000 habitants a diminué de 9,95 en 2008 à 0,46 en 2012, mais a ensuite augmenté à plus de 1,96 en 2013. Le nombre de provinces ayant signalé une incidence annuelle inférieure à un cas pour un million d'habitants a augmenté de 1 en 2009 à 15 en 2012, mais est retombé à 1 en 2013. L'âge médian des cas a diminué de 83 mois en 2005 à 14 mois en 2012 et à 11 mois pendant la période allant de janvier à octobre 2013. Entre 2008 et 2012, l'incidence de la rougeole dans tous les groupes d'âge, y compris ceux qui ne sont pas ciblés pour la vaccination, a diminué d'au moins 93,6%. Cependant, la résurgence a commencé à la fin de l'année 2012 et s'est poursuivie en 2013. Parmi les cas signalés de janvier à octobre 2013, 40% étaient âgés de 8 mois à 6 ans. Conclusion Bien qu'il y ait des preuves de progrès vers l'objectif d'élimination de la rougeole en Chine, la résurgence de 2013 indique que de nombreux enfants n'étaient toujours pas vaccinés à temps. La vaccination de routine doit être renforcée et les lacunes immunitaires restantes doivent être identifiées et comblées.